area	phase	phasenum	supported	total	pg_mean	pg_l95	pg_u95
all	Preclinical	1	506	10839	0.046683273364701544	0.042869850504123605	0.05081790308691531
all	Phase I	2	175	4421	0.039583804569102016	0.03422466013818298	0.04574237644689722
all	Phase II	3	295	7383	0.03995665718542598	0.035723084529916814	0.044668712441924614
all	Phase III	4	90	1551	0.058027079303675046	0.04744695104017023	0.0707911225446009
all	Launched	5	189	1519	0.12442396313364056	0.10876680062941228	0.1419759517490241
hematology	Preclinical	1	38	216	0.17592592592592593	0.13093949373431782	0.23223794899641834
hematology	Phase I	2	13	148	0.08783783783783784	0.052050941964620484	0.1444794328912558
hematology	Phase II	3	15	213	0.07042253521126761	0.04313817437700724	0.11292727087844817
hematology	Phase III	4	10	66	0.15151515151515152	0.08443636982671276	0.25692904869787664
hematology	Launched	5	33	83	0.39759036144578314	0.2990893171041682	0.5051516499309349
metabolic	Preclinical	1	118	811	0.14549938347718866	0.12290281762529372	0.1714384388539881
metabolic	Phase I	2	39	233	0.16738197424892703	0.12492769573526301	0.22062607355921657
metabolic	Phase II	3	68	296	0.22972972972972974	0.18545284086369204	0.280931825788826
metabolic	Phase III	4	16	67	0.23880597014925373	0.15268139048492926	0.353257637555303
metabolic	Launched	5	53	94	0.5638297872340425	0.4630290566620046	0.6596183378539684
respiratory	Preclinical	1	27	577	0.04679376083188908	0.032356121458223225	0.06722605874312117
respiratory	Phase I	2	9	226	0.03982300884955752	0.021090120105497257	0.07393824828705313
respiratory	Phase II	3	21	412	0.050970873786407765	0.03357675192563021	0.07666107513158106
respiratory	Phase III	4	8	114	0.07017543859649122	0.03598534342897001	0.13238883505845522
respiratory	Launched	5	12	70	0.17142857142857143	0.1008772464052925	0.2761664803214543
endocrine	Preclinical	1	36	473	0.07610993657505286	0.055480265472905056	0.1035693670994436
endocrine	Phase I	2	17	157	0.10828025477707007	0.06871130462116902	0.16656049096034045
endocrine	Phase II	3	16	240	0.06666666666666667	0.041448900547079	0.10553783006893863
endocrine	Phase III	4	0	32	0	0	0.10717919825507058
endocrine	Launched	5	13	56	0.23214285714285715	0.1409937910920862	0.35768153215010845
infection	Preclinical	1	5	431	0.01160092807424594	0.004965123061464938	0.026865923725639184
infection	Phase I	2	1	101	0.009900990099009901	0.0017499112489682282	0.05396715799445504
infection	Phase II	3	2	241	0.008298755186721992	0.002278775977146227	0.029747903076570312
infection	Phase III	4	2	83	0.024096385542168676	0.006633166140727596	0.08366309243416316
infection	Launched	5	2	46	0.043478260869565216	0.012005445598556616	0.14532259026219066
congenital	Preclinical	1	76	488	0.1557377049180328	0.12626811324685555	0.19058492145737777
congenital	Phase I	2	14	142	0.09859154929577464	0.05964033836706019	0.15868892875746743
congenital	Phase II	3	47	255	0.1843137254901961	0.14153120564761695	0.23646642760042977
congenital	Phase III	4	12	97	0.12371134020618557	0.07220400208023732	0.20388739074856863
congenital	Launched	5	46	113	0.40707964601769914	0.3210007774543553	0.4992684984348923
neurology	Preclinical	1	73	1368	0.0533625730994152	0.042654268986709334	0.06657224392937178
neurology	Phase I	2	23	435	0.052873563218390804	0.03548769948952704	0.07808739196749687
neurology	Phase II	3	47	647	0.07264296754250386	0.05506619340645865	0.09526451692963461
neurology	Phase III	4	12	216	0.05555555555555555	0.032062337869442875	0.09458101216128095
neurology	Launched	5	34	189	0.17989417989417988	0.13168555237905377	0.24085601238629586
cardiovascular	Preclinical	1	56	958	0.05845511482254697	0.04528793408113601	0.07514923127325242
cardiovascular	Phase I	2	9	225	0.04	0.021184481988475477	0.07425914493669515
cardiovascular	Phase II	3	24	366	0.06557377049180328	0.04445798150568069	0.0957141316641081
cardiovascular	Phase III	4	7	141	0.04964539007092199	0.02425353032448804	0.09892569588574283
cardiovascular	Launched	5	17	108	0.1574074074074074	0.10066202670916789	0.23768709015421374
oncology	Preclinical	1	39	3626	0.01075565361279647	0.007878077393653935	0.01466876376983968
oncology	Phase I	2	20	2160	0.009259259259259259	0.006001943062717521	0.014258995483393877
oncology	Phase II	3	43	3874	0.01109963861641714	0.00825108342023499	0.014916820625026354
oncology	Phase III	4	9	589	0.015280135823429542	0.008059363439798394	0.02878262609335959
oncology	Launched	5	16	554	0.02888086642599278	0.017854060666294833	0.04639619942814998
digestive	Preclinical	1	44	641	0.0686427457098284	0.051528595147919236	0.09089627156064603
digestive	Phase I	2	15	227	0.06607929515418502	0.04045038177030882	0.10615005557565528
digestive	Phase II	3	34	402	0.0845771144278607	0.061153998214841736	0.1158645326899434
digestive	Phase III	4	6	94	0.06382978723404255	0.029579735297574024	0.1323297355099437
digestive	Launched	5	10	60	0.16666666666666666	0.09313176979191455	0.2803161316361453
psychiatry	Preclinical	1	32	689	0.04644412191582003	0.03308833872068823	0.06482938539496887
psychiatry	Phase I	2	17	273	0.06227106227106227	0.03923897559774508	0.09745102373217267
psychiatry	Phase II	3	23	361	0.06371191135734072	0.0428263798141135	0.09378490055353061
psychiatry	Phase III	4	10	119	0.08403361344537816	0.04628480919483177	0.14779835335938682
psychiatry	Launched	5	17	121	0.14049586776859505	0.08960531687145493	0.21351080479326087
immune	Preclinical	1	63	1049	0.06005719733079123	0.04722132351627224	0.07610347314032198
immune	Phase I	2	32	388	0.08247422680412371	0.05902451105329811	0.11411045793358045
immune	Phase II	3	40	464	0.08620689655172414	0.06394584154318142	0.11526328419791154
immune	Phase III	4	12	117	0.10256410256410256	0.05964962202773448	0.17074695785802793
immune	Launched	5	17	114	0.14912280701754385	0.0952378373401679	0.22588394101691392
signs/symptoms	Preclinical	1	66	1034	0.06382978723404255	0.05048477433608768	0.08040367463284408
signs/symptoms	Phase I	2	19	258	0.07364341085271318	0.047649775999917654	0.11214714466017789
signs/symptoms	Phase II	3	25	381	0.06561679790026247	0.04483694894921706	0.0950686084865269
signs/symptoms	Phase III	4	8	115	0.06956521739130435	0.0356686537914928	0.13128872806487235
signs/symptoms	Launched	5	15	118	0.1271186440677966	0.07857091225474364	0.19917903549084534
dermatology	Preclinical	1	37	719	0.05146036161335188	0.03756252239555018	0.07012562674256291
dermatology	Phase I	2	22	305	0.07213114754098361	0.04811377883389417	0.10679242774658218
dermatology	Phase II	3	29	571	0.050788091068301226	0.03559186220168961	0.07198816333711526
dermatology	Phase III	4	11	122	0.09016393442622951	0.0510925438426064	0.15425678270576482
dermatology	Launched	5	13	148	0.08783783783783784	0.052050941964620484	0.1444794328912558
ophthalmology	Preclinical	1	23	524	0.04389312977099236	0.02942384757768853	0.06500120749860303
ophthalmology	Phase I	2	4	104	0.038461538461538464	0.015056813343976884	0.09474751376905563
ophthalmology	Phase II	3	19	286	0.06643356643356643	0.04293928256031791	0.101420530528322
ophthalmology	Phase III	4	7	71	0.09859154929577464	0.04858282372396935	0.1898072224059285
ophthalmology	Launched	5	6	63	0.09523809523809523	0.04438348427689202	0.1926170106283689
musculoskeletal	Preclinical	1	25	472	0.05296610169491525	0.0361306724417418	0.07701932284057884
musculoskeletal	Phase I	2	16	157	0.10191082802547771	0.06370762918389643	0.1591295614477189
musculoskeletal	Phase II	3	15	226	0.06637168141592921	0.04063120791002547	0.10660706230603165
musculoskeletal	Phase III	4	6	76	0.07894736842105263	0.03668400523347176	0.16172743482138072
musculoskeletal	Launched	5	8	80	0.1	0.05154761556738084	0.1851068880610409
other	Preclinical	1	18	264	0.06818181818181818	0.04356005319778895	0.10519010294351962
other	Phase I	2	4	60	0.06666666666666667	0.026228698724506196	0.15925357313197164
other	Phase II	3	6	126	0.047619047619047616	0.022004488387951104	0.10000167947689509
other	Phase III	4	3	32	0.09375	0.0324015512983662	0.24218154728387864
other	Launched	5	1	36	0.027777777777777776	0.004920407139810455	0.1416971865327385
